Mosseri Marlio Charles bought NVCT
October 23, 2025 · Form 4 insider transaction
Mosseri Marlio Charles bought 46,900 shares of Nuvectis Pharma, Inc. at $6.06 per share, a transaction worth $284.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
46,900
Price
$6.06
Total value
$284.2K
InsiderMosseri Marlio Charles
Role—
CompanyNuvectis Pharma, Inc. (NVCT)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateOctober 23, 2025
Filing dateOctober 29, 2025
Shares owned after3,028,706
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF.